Fast Five Quiz: Scleroderma Systemic Sclerosis ILD Presentation and Diagnosis

Zab Mosenifar, MD

January 28, 2022

PFTs in patients with SSc-ILD generally demonstrate a restrictive pattern, with reduced forced vital capacity (FVC) and diffusion capacity of the lung for carbon monoxide. However, FVC may be normal and this measure is not always indicative of fibrosis.

Analysis of bronchoalveolar lavage from patients with SSc-ILD typically shows increased number of granulocytes.

The most common symptoms of SSc-ILD are dyspnea, fatigue, and nonproductive cough.

HRCT scan of the chest may reveal active alveolitis or fibrosis and correlates with yield of biopsy in sarcoidosis.

Learn more about the clinical presentation of CTD-ILD.

1 2 3 4 5 6

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Zab Mosenifar. Fast Five Quiz: Scleroderma Systemic Sclerosis ILD Presentation and Diagnosis - Medscape - Jan 28, 2022.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.